A computer program for the analysis of crossover designs
β Scribed by Rose E. Gaines Das; Martyn R. Hughes
- Publisher
- Elsevier Science
- Year
- 1979
- Weight
- 494 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0010-468X
No coin nor oath required. For personal study only.
β¦ Synopsis
We describe a program, CROSS, which we have written to obtain potency estimates and other parameters for bioassay data from assays of crossover design. The program permits testing of all assays for statistical validity and calculates the complete analysis of variance for assays of balanced design. The form of data input and the complete documentation of assay results make this program particularly useful for anyone carrying out crossover assays on a routine basis. The analysis of variance presented is also useful for more general biological or medical situations.
π SIMILAR VOLUMES
Application software for economical and convenient calculation of median effective doses, confidence limits, potency ratios and slopes of quantal dose-response curves using a microcomputer is presented. The PASCAL language program is stored on diskette and it is compatible with many commercially ava
This program has been developed for the estimation and statistical evaluation of binding parameters. Binding of small molecules to protein mixtures is measured at equilibrium and the results analyzed on the assumption that each binding system is independent and follows the law of mass action. Briefl
This paper presents the details and logic of a Fortran computer program which carries out routine clinical analysis of dental models resulting from impressions of the teeth and related structures, which are subsequently cast in plaster of Paris . The program is primarily intended for use by the orth
Considerations of safety, time, finance, and ethics suggest the application of game playing to the teaching of experimental design methods. By using a computer an inexhaustible supply of subjects with varying attributes can be generated and their responses to different treatments can be monitored at